Can Blood Filtration Reduce PFAS?
Multi-platform analysis links therapeutic apheresis to reductions in circulating PFAS and selected plastic-associated signals
False
Multi-platform analysis links therapeutic apheresis to reductions in circulating PFAS and selected plastic-associated signals
Therapeutic apheresis may reduce circulating PFAS and microplastic-related signals, according to preliminary data from Technische Universität Dresden.
In a study of 34 patients, significant reductions in C-reactive protein, fibrinogen, LDL cholesterol, and lipoprotein(a) were observed after double filtration plasmapheresis.
Liquid chromatography-tandem mass spectrometry revealed up to 25% reductions in PFAS levels in samples from 14 patients after treatment.
Pyrolysis gas chromatography-mass spectrometry indicated decreases in polyethylene and polyvinyl chloride in blood samples from treated patients.
The findings are preliminary, and the study does not confirm a shared clearance mechanism or resolve challenges in measuring microplastics in blood.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
April 3, 2025
13 min read
Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change
December 3, 2024
3 min read
Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer
December 5, 2024
6 min read
Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards
Affiliations:
Specialties:
Areas of Expertise:
False